HeartBeam rises on new CEO appointment
** Shares of heart device maker HeartBeam BEAT.O up 3.51% at
$2.34
** Co appoints Robert Eno as new CEO, replacing Branislav
Vajdic as CEO
** Eno joined Co as President in January 2023; Branislav
Vajdic to move into role of President
** Co continues to work towards FDA 510(k) clearance for its
vector-based technology, which captures the heart’s electrical
signals from three dimensions
** Including session's move, stocks down 0.43% YTD
(Reporting by Khusbu Jena in Bengaluru)
((Khusbu.Jena@thomsonreuters.com;))
Recent news on HeartBeam
See all newsBrief: Heartbeam Receives FDA Breakthrough Device Designation For Heart Attack Assessment
Brief: HeartBeam Will Not Build Large Commercial Organization For Arrhythmia Indication
Brief: Heartbeam, Inc. Enters Into At-The-Market Equity Offering Sales Agreement For Up To $25 Million In Common Stock
HeartBeam, Inc. reports results for the quarter ended June 30 - Earnings Summary
HeartBeam Q2 loss per share narrows; co lowers FY net operating cash outflow guidance